Neurocrine Biosciences NBIX Price / earnings
Price / earnings at other companies
Other financials
Where this comes from
Calculated from Neurocrine Biosciences’s reported figures.
Based on the most recent quarter.
The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neurocrine Biosciences's price / earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neurocrine Biosciences's price / earnings?
- Neurocrine Biosciences (NBIX) reported price / earnings of 19.8× in Q1 2026.
- How has Neurocrine Biosciences's price / earnings changed year-over-year?
- Neurocrine Biosciences's price / earnings decreased by 45.2% year-over-year, from 36.1× to 19.8×.
- What is the long-term trend for Neurocrine Biosciences's price / earnings?
- Over 4 years (2021 to 2025), Neurocrine Biosciences's price / earnings has grown at a -3.0% compound annual growth rate (CAGR), from 152.1× to 134.6×.
- What does price / earnings mean?
- How many dollars investors pay for each dollar of the company's annual profit.
- How do you interpret price / earnings?
- Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
- How does price / earnings compare across companies?
- Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.